CHERICE STEBBINS: Open Payments
NPI 1922713072 · CENTRAL SQUARE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,230 in 40 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $526 · 2025 $3,230
Food & beverage: $3,052Education: $179
| Company | Payments | Amount |
|---|---|---|
| Lumenis BE inc | 1 | $2,071 |
| Janssen Biotech, Inc. | 10 | $274 |
| REVANCE THERAPEUTICS, INC. | 2 | $269 |
| Regeneron Healthcare Solutions, Inc. | 11 | $221 |
| Amgen Inc. | 3 | $113 |
| GENZYME CORPORATION | 3 | $84 |
| ABBVIE INC. | 3 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
| AERIN MEDICAL INC. | 1 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
Products named: M22, DUPIXENT, TREMFYA, DAXXIFY, OTEZLA, SKYRIZI, Winlevi, VIVAER STYLUS.
Industry payments across NY — which companies pay providers there.
